Related Experiment Video
Updated: Mar 26, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Effectiveness of a multi-level asthma intervention in increasing controller medication use: a randomized control
Glorisa Canino1, Patrick E Shrout2, Doryliz Vila1
1a Behavioral Sciences Institute, University of Puerto Rico, Medical Sciences Campus , San Juan , Puerto Rico .
The CALMA-plus intervention, designed to improve asthma self-management in Puerto Rican families, did not significantly increase controller medication use compared to the original CALMA intervention. Both groups showed improvements in asthma symptoms and service utilization.
Area of Science:
- Pediatric Asthma Management
- Public Health Interventions
- Healthcare Disparities
Background:
- Poor family self-management contributes to high asthma morbidity in Puerto Rico.
- The prior CALMA intervention improved asthma outcomes but not controller medication use.
- CALMA-plus was developed to enhance CALMA with provider training and clinic-based screening.
Purpose of the Study:
- To evaluate the efficacy of the CALMA-plus intervention compared to CALMA-only.
- To determine if CALMA-plus increases controller medication use in pediatric asthma patients.
- To assess the impact on asthma symptom reduction and service utilization.
Main Methods:
- 404 children with asthma from Medicaid claims data in San Juan, Puerto Rico were included.
- Eight clinics were paired and randomized to either CALMA-only or CALMA-plus interventions.
- Outcomes were assessed at 12 months post-intervention.
Main Results:
- No statistically significant difference was found between CALMA-plus and CALMA-only for controller medication use.
- Small, non-significant differences favored CALMA-plus for decreasing asthma symptoms.
- Both intervention groups demonstrated reduced asthma symptoms and service utilization.
Conclusions:
- Provider compliance, limited clinic numbers, and medication barriers may explain the lack of difference.
- Future interventions require enhanced provider support and resources for successful implementation.
- The study highlights the need for tailored strategies to improve pediatric asthma care in underserved populations.
Related Concept Videos
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
